Director, Investor Relations & Communications

About Peptilogics Peptilogics is a surgical therapeutics biotechnology company dedicated to curing and preventing devastating medical device-related infections (MDRI). Our lead candidate, zaloganan (PLG0206), is a first-in-class drug that targets biofilm, a protective bacterial matrix that is the root cause of device infections across surgical categories and has no approved cure to date. Zaloganan is currently being evaluated in a Phase 2/3 registrational trial for the treatment of prosthetic joint infection (PJI), the first of multiple potential indications to treat and prevent MDRI. Position Overview The Director, Investor Relations & Communications leads all external communications tied to Peptilogics' corporate narrative, investor engagement, and public positioning.

This individual is the key point of contact for current and prospective investors, analysts, and media, ensuring consistent, transparent, and compelling messaging across every channel, and also supports strategic internal communications and cross-functional alignment around value-creating milestones. Reporting to the COO (CFO once hired), the role collaborates closely with Finance, Clinical, Regulatory, and Corporate Operations to shape disclosures, presentations, and communications strategy. The ideal candidate brings deep life-sciences IR experience, thrives in a fast-paced, high-stakes environment, and can build a compelling narrative for a category-defining asset where there may be no clear analogs of success, building the investor infrastructure and external positioning needed to support future raises and long-term market shaping.